These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21040992)

  • 21. Study of volumetric and dosimetric changes during fractionated radiotherapy in head and neck cancers: A single centre experience.
    Kumar V; Nautiyal V; Kant R; Gupta M; Bansal S; Ahmad M
    J Cancer Res Ther; 2021; 17(1):235-241. PubMed ID: 33723161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
    Luo Y; Gao Y; Yang G; Lang J
    Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Qu S; Liang ZG; Zhu XD
    Asian Pac J Cancer Prev; 2015; 16(5):1687-92. PubMed ID: 25773811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer.
    Thomson DJ; Beasley WJ; Garcez K; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
    Med Dosim; 2016; 41(2):154-8. PubMed ID: 26993081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma.
    Wu VW; Leung WS; Wong KL; Chan YK; Law WL; Leung WK; Yu YL
    Radiat Oncol; 2016 Aug; 11(1):109. PubMed ID: 27558690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of anatomical and dosimetric variations in the first 15 fractions, and between fractions 16 and 25, of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Yang H; Tu Y; Wang W; Hu W; Ding W; Yu C; Zhou C
    J Appl Clin Med Phys; 2013 Nov; 14(6):3918. PubMed ID: 24257268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified VMAT adaptive radiotherapy for nasopharyngeal cancer patients based on CT-CT image fusion.
    Jin X; Han C; Zhou Y; Yi J; Yan H; Xie C
    Radiat Oncol; 2013 Nov; 8():277. PubMed ID: 24279414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actual anatomical and dosimetric changes of parotid glands in nasopharyngeal carcinoma patients during intensity modulated radiation therapy.
    Ren G; Xu SP; Du L; Feng LC; Qu BL; Liu HX; Xie CB; Ma L
    Biomed Res Int; 2015; 2015():670327. PubMed ID: 25793202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.
    Wang X; Lu J; Xiong X; Zhu G; Ying H; He S; Hu W; Hu C
    Med Dosim; 2010; 35(2):151-7. PubMed ID: 19931037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?
    Chen C; Fei Z; Chen L; Bai P; Lin X; Pan J
    Med Dosim; 2014; 39(1):34-7. PubMed ID: 24140235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.
    Chen SW; Yang SN; Liang JA; Shiau AC; Lin FJ
    Med Dosim; 2005; 30(4):219-27. PubMed ID: 16275564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.
    Yan D; Yan S; Wang Q; Liao X; Lu Z; Wang Y
    BMC Cancer; 2013 Nov; 13():548. PubMed ID: 24237861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
    Wu MY; He XY; Hu CS
    PLoS One; 2016; 11(4):e0154501. PubMed ID: 27119991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
    Lu SH; Cheng JC; Kuo SH; Lee JJ; Chen LH; Wu JK; Chen YH; Chen WY; Wen SY; Chong FC; Wu CJ; Wang CW
    Radiother Oncol; 2012 Sep; 104(3):324-30. PubMed ID: 22236614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Design planning target volumes (PTVs) in intensity-modulated radiotherapy for nasopharyngeal carcinoma].
    Lin CG; Li GW; Lin LW; Wu YQ; Xiao DY; Zhao C; Lu TX; Cui NJ
    Ai Zheng; 2007 Feb; 26(2):200-3. PubMed ID: 17298753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
    Zhou X; Wang W; Zhou C; Zhu J; Ding W; Chen M; Chen K; Shi Y; Chen X; Kong FM; Yang H
    Radiother Oncol; 2022 May; 170():136-142. PubMed ID: 35288229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
    Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
    Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.